Vulnerable and Marginalized Groups Planning Framework
Guidelines
HIV drug resistance
July 2017
Summary of current WHO recommendations and guidance on programmatic approaches
This reference manual provides in-depth knowledge on the techniques, methodologies and best practices for using geospatial information in support of decision making for disaster risk management for specific hazards
First Revised Edition
March 2000
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...d over 15 million people with lymphoedema. At least 36 million persons remain with these chronic disease manifestations. The disease is endemic in 72 countries. In 2016, an estimated total population of 856 million were living in areas with ongoing transmission of the causative filarial parasites and requiring mass drug administration (MDA). Lymphatic filariasis disfigures and disables, and often leads to stigmatization and poverty. Hundreds of millions of dollars are lost annually due to reduced productivity of affected patients. WHO has ranked the disease as one of the world’s leading causes of permanent and long-term disability.
more
DRUGS REGULATORY UNIT | NOVEMBER 2009 | SECOND EDITION